Stichting European Myeloma Network
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Employees
- -
- Market Cap
- -
Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-05-20
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- European Myeloma Network B.V.
- Target Recruit Count
- 63
- Registration Number
- NCT01857115
- Locations
- 🇮🇹
Fondazione EMN Italy Onlus, Torino, Italy
Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-10-26
- Last Posted Date
- 2017-07-06
- Lead Sponsor
- Stichting European Myeloma Network
- Target Recruit Count
- 49
- Registration Number
- NCT01460420
- Locations
- 🇮🇹
Azienda Ospedaliera Universitaria di Udine, Udine, Italy
🇮🇹S Giovanni Battista Hospital, Torino, Italy
🇩🇪Medizinische Klinik and Poliklinik II, University Hospital, Würzburg,, Germany
Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-05-03
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- Stichting European Myeloma Network
- Target Recruit Count
- 58
- Registration Number
- NCT01346787
- Locations
- 🇮🇹
Divisione di Ematologia Ospedale S. Eugenio, Roma, Italy
🇮🇹Divisione di Ematologia Dipartimento di Medicina Clinica e Sperimentale Università Amedeo Avogadro, Novara, Italy
🇮🇹SC Ematologia - A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy
A Trial for Systemic Light-chain (AL) Amyloidosis
- First Posted Date
- 2011-01-14
- Last Posted Date
- 2017-03-10
- Lead Sponsor
- Stichting European Myeloma Network
- Target Recruit Count
- 110
- Registration Number
- NCT01277016
- Locations
- 🇮🇹
Amyloidosis Research and Treatment Center, Pavia, Italy
Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-08-30
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Stichting European Myeloma Network
- Target Recruit Count
- 150
- Registration Number
- NCT01190787
- Locations
- 🇮🇹
A.O.U. Città della Salute e della Scienza di Torino - SC Ematologia U, Torino, Italy
Bortezomib, Dexamethasone, and Rituximab in Untreated Waldenstroms Macroglobulinemia
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-01-30
- Last Posted Date
- 2015-02-18
- Lead Sponsor
- Stichting European Myeloma Network
- Target Recruit Count
- 59
- Registration Number
- NCT00832234
- Locations
- 🇬🇷
University of Athens School of Medicine, Athens, Greece
© Copyright 2024. All Rights Reserved by MedPath